JB

Jaya Bharathi Bandi

Active Director Director DIN 10450164
DIN 10450164 First appointment Jan 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Jaya Bharathi Bandi

Data last updated:

Jaya Bharathi Bandi is a Director at Dodecane Pharma Private Limited (since 2024). Dodecane Pharma Private Limited reported revenue of ₹2.80 Cr (FY 2025).

DIN 10450164
Primary Designation Director
First Appointment 02 Jan 2024
Oldest Company Age 2 yrs
Largest company Dodecane Pharma Private Limited · ₹2.80 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dodecane Pharma Private Limited U46497TS2024PTC180688
Director02 Jan 20242024₹2.80 Cr (FY 2025)Active

Board colleagues of Jaya Bharathi Bandi

NameDINCompanyDesignation
Prahallda Narasimhulu Shella11528257Dodecane Pharma Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Dodecane Pharma Private Limited
Premium access

Shareholding and investment profile for Jaya Bharathi Bandi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jaya Bharathi Bandi

Jaya Bharathi Bandi currently holds 1 directorship: Dodecane Pharma Private Limited (Director, since 02 Jan 2024, revenue ₹2.80 Cr (FY 2025)).

Jaya Bharathi Bandi was first appointed on 02 Jan 2024 as Director at Dodecane Pharma Private Limited.

The current boards of Jaya Bharathi Bandi's companies include Prahallda Narasimhulu Shella (Dodecane Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available